Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-3.22%
↑ 59% above average
Average (9y)
-7.95%
Historical baseline
Range
High:27.96%
Low:-92.13%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -3.22% |
| 2023 | 24.96% |
| 2022 | 19.23% |
| 2021 | 12.80% |
| 2020 | -14.40% |
| 2019 | -92.13% |
| 2018 | -32.25% |
| 2017 | 27.96% |
| 2016 | -43.79% |
| 2015 | 21.38% |